Your browser doesn't support javascript.
loading
Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension.
Bringhen, S; Milan, A; D'Agostino, M; Ferri, C; Wäsch, R; Gay, F; Larocca, A; Offidani, M; Zweegman, S; Terpos, E; Goldschmidt, H; Cavo, M; Ludwig, H; Driessen, C; Auner, H W; Caers, J; Gramatzki, M; Dimopoulos, M A; Boccadoro, M; Einsele, H; Sonneveld, P; Engelhardt, M.
Afiliação
  • Bringhen S; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy.
  • Milan A; Department of Medical Sciences, Internal Medicine and Hypertension Division, AOU Città della Salute e della Scienza di Torino, Rete Oncologica Piemontese, University of Torino, Torino, Italy.
  • D'Agostino M; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy.
  • Ferri C; University of L'Aquila, MeSVA Department - San Salvatore Hospital, Division of Internal Medicine & Nephrology, Coppito, Italy.
  • Wäsch R; Department of Medicine I, Hematology, Oncology & Stem Cell Transplantation, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Gay F; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy.
  • Larocca A; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy.
  • Offidani M; Clinica di Ematologia, AOU Ospedali Riuniti di Ancona, Ancona, Italy.
  • Zweegman S; Amsterdam UMC, Vrije Universiteit Amsterdam, VU University Medical Center, Department of Hematology, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Terpos E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Goldschmidt H; University Clinic Heidelberg, Internal Medicine V and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Cavo M; 'Seràgnoli' Institute of Hematology and Medical Oncology, University of Bologna, Bologna, Italy.
  • Ludwig H; 1. Medical Department and Oncology, Wilhelminenspital Wien, Vienna, Austria.
  • Driessen C; Department of Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Auner HW; Faculty of Medicine, Department of Medicine, Imperial College London, London, UK.
  • Caers J; Department of Hematology, Domaine University Liege, Liege, Belgium.
  • Gramatzki M; Division of Stem Cell Transplantation and Immunotherapy, University of Kiel, Kiel, Germany.
  • Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
  • Boccadoro M; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy.
  • Einsele H; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Sonneveld P; Department of Hematology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Engelhardt M; Department of Medicine I, Hematology, Oncology & Stem Cell Transplantation, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
J Intern Med ; 286(1): 63-74, 2019 07.
Article em En | MEDLINE | ID: mdl-30725503
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Doenças Cardiovasculares / Mieloma Múltiplo Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Doenças Cardiovasculares / Mieloma Múltiplo Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article